Beyond the Session: A Smarter Mental Health Model

To meaningfully scale mental health care — and improve outcomes along the way — we must move beyond the rigid constraints of episodic care and toward a model that is continuous, intelligent, and adaptive to individual needs. The post Beyond the Session: A Smarter Mental Health Model appeared first on MedCity News.

Read More

This Geriatrics Training Program Escaped the Ax. For Now.

In St. Louis, a team of students aboard a well-equipped van visits senior centers, a nursing home, a church, and other sites, learning to conduct comprehensive, hourlong geriatric assessments. The team — future doctors, social workers, psychologists, and therapists — looks for such common problems as frailty, muscle weakness, and cognitive decline. The patients they…

Read More

This Geriatrics Training Program Escaped the Ax. For Now.

In St. Louis, a team of students aboard a well-equipped van visits senior centers, a nursing home, a church, and other sites, learning to conduct comprehensive, hourlong geriatric assessments. The team — future doctors, social workers, psychologists, and therapists — looks for such common problems as frailty, muscle weakness, and cognitive decline. The patients they…

Read More

AHA/ACC Statement on Cost/Value Methodology (2025 Update)

Last month, the American Heart Association (AHA) and American College of Cardiology (ACA) put out a statement on how new cardiovascular medical technologies should be evaluated from a cost and value standpoint (Kazi et al. 2025). This is an update from their 2014 cost/value methodology (Anderson et al. 2014). What does the AHA/ACC statement say?…

Read More

Boehringer Ingelheim Drug Wins FDA Approval for Treating Fatal Lung Disorder IPF

Boehringer Ingelheim’s Jascayd blocks a protein involved in the lung inflammation that develops from idiopathic pulmonary fibrosis, a rare and ultimately fatal disease with few available therapies. The twice-daily pill doesn’t cure IPF but clinical trial results showed it slowed disease progression. The post Boehringer Ingelheim Drug Wins FDA Approval for Treating Fatal Lung Disorder…

Read More

How Are Healthcare Leaders Tackling Automation Bias?

At MedCity News’ INVEST Digital Health conference, healthcare experts explored strategies to mitigate automation bias — emphasizing the importance of vendor responsibility, use case-specific governance and clinician engagement. The post How Are Healthcare Leaders Tackling Automation Bias? appeared first on MedCity News.

Read More